litlas
Log inCreate account

David B. Badesch

Active 1989–2025

96
Papers
40,029
Citations
79
h-index
96
i10-index

Citations

Citations per year for David B. Badesch1960: 5 citations1979: 1 citations1982: 1 citations1985: 1 citations1989: 1 citations1990: 2 citations1992: 2 citations1993: 1 citations1994: 1 citations1995: 3 citations1996: 6 citations1997: 17 citations1998: 36 citations1999: 47 citations2000: 64 citations2001: 65 citations2002: 121 citations2003: 147 citations2004: 191 citations2005: 181 citations2006: 236 citations2007: 217 citations2008: 315 citations2009: 328 citations2010: 306 citations2011: 307 citations2012: 342 citations2013: 454 citations2014: 315 citations2015: 302 citations2016: 240 citations2017: 190 citations2018: 237 citations2019: 748 citations2020: 775 citations2021: 644 citations2022: 634 citations2023: 396 citations2024: 783 citations2025: 417 citations2026: 12 citations1961–1978: no citations, so these years are not shown1980–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986–1988: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,356 citing papers, 30.2% of this breakdownUnited Kingdom: 678 citing papers, 8.7% of this breakdownGermany: 550 citing papers, 7% of this breakdownFrance: 512 citing papers, 6.6% of this breakdownChina: 451 citing papers, 5.8% of this breakdownItaly: 378 citing papers, 4.8% of this breakdownCanada: 359 citing papers, 4.6% of this breakdownNetherlands: 243 citing papers, 3.1% of this breakdownJapan: 216 citing papers, 2.8% of this breakdownSwitzerland: 213 citing papers, 2.7% of this breakdownAustralia: 171 citing papers, 2.2% of this breakdownBelgium: 166 citing papers, 2.1% of this breakdown
0%30.2%Other 19.4%

Institutions

Fields

  • Medicine90.6%
  • Biochemistry, Genetics and Molecular Biology6.1%
  • Immunology and Microbiology0.7%
  • Engineering0.5%
  • Computer Science0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.2%

Topics

  • Pulmonary Hypertension Research and Treatments24.6%
  • Cardiovascular Function and Risk Factors4.8%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis4.3%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.3%
  • Heart Failure Treatment and Management3.3%
  • Cardiovascular Issues in Pregnancy3.1%
  • Other56.6%

Coauthors

All papers

Open in search
  1. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension

    Authors: Marius M. Hoeper, David B. Badesch, Hossein Ardeschir Ghofrani, J. Simon R. Gibbs, Mardi Gomberg‐Maitland, Vallerie V. McLaughlin, Ioana R. Preston, Rogério Souza, Aaron B. Waxman, Ekkehard Grünig, Grzegorz Kopeć, G. Meyer, Karen M. Olsson, Stephan Rosenkranz, Yayun Xu, B.I. Miller, Marcie Fowler, John Butler, Joerg Koglin, Janethe de Oliveira Pena, Marc Humbert - New England Journal of Medicine 2023 cited by 665

  2. Sotatercept for the Treatment of Pulmonary Arterial Hypertension

    Authors: Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs, Mardi Gomberg‐Maitland, Marius M. Hoeper, Ioana R. Preston, Rogério Souza, Aaron B. Waxman, Pilar Escribano Subías, Jeremy Feldman, G. Meyer, David Montani, Karen M. Olsson, Solaiappan Manimaran, Jennifer Barnes, Peter G. Linde, Janethe de Oliveira Pena, David B. Badesch - New England Journal of Medicine 2021 cited by 585

  3. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension

    Authors: Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs, Mardi Gomberg‐Maitland, Marius M. Hoeper, Ioana R. Preston, Rogério Souza, Aaron B. Waxman, Hossein Ardeschir Ghofrani, Pilar Escribano Subías, Jeremy Feldman, G. Meyer, David Montani, Karen M. Olsson, Solaiappan Manimaran, Janethe de Oliveira Pena, David B. Badesch - European Respiratory Journal 2022 cited by 145

  4. Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension

    Authors: Nazzareno Galiè, Hossein Ardeschir Ghofrani, Adam Torbicki, Robyn J. Barst, Lewis J. Rubin, David B. Badesch, Thomas R. Fleming, Tamiza Parpia, Gary Burgess, Angelo Branzi, Friedrich Grimminger, Marcin Kurzyna, Gérald Simonneau - New England Journal of Medicine 2005 cited by 2,470

  5. Predicting Survival in Pulmonary Arterial Hypertension

    Authors: Raymond L. Benza, Dave P. Miller, Mardi Gomberg‐Maitland, Robert P. Frantz, Aimee J. Foreman, Christopher S. Coffey, Adaani Frost, Robyn J. Barst, David B. Badesch, C. Gregory Elliott, Theodore G. Liou, Michael D. McGoon - Circulation 2010 cited by 1,550

  6. Pulmonary Arterial Hypertension

    Authors: David B. Badesch, Gary E. Raskob, C. Gregory Elliott, Abby Krichman, Harrison W. Farber, Adaani Frost, Robyn J. Barst, Raymond L. Benza, Theodore G. Liou, Michelle Turner, Scott Giles, Kathy Feldkircher, Dave P. Miller, Michael D. McGoon - CHEST Journal 2009 cited by 1,180

  7. Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial

    Authors: Rogério Souza, David B. Badesch, Hossein Ardeschir Ghofrani, J. Simon R. Gibbs, Mardi Gomberg‐Maitland, Vallerie V. McLaughlin, Ioana R. Preston, Aaron B. Waxman, Ekkehard Grünig, Grzegorz Kopeć, Gisela Meyer, Karen M. Olsson, Stephan Rosenkranz, Jianxin Lin, Amy O. Johnson‐Levonas, Janethe de Oliveira Pena, Marc Humbert, Marius M. Hoeper - European Respiratory Journal 2023 cited by 102

  8. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

    Authors: Kevin Y. Chang, Sue Duval, David B. Badesch, Todd M. Bull, Murali M. Chakinala, Teresa De Marco, Robert P. Frantz, Anna R. Hemnes, Stephen C. Mathai, Erika B. Rosenzweig, John Ryan, Thenappan Thenappan, Roblee P. Allen, Sonja Bartolome, Raymond L. Benza, Linda Cadaret, Michael Eggert, Jean Elwing, Jeffrey R. Fineman, Raymond Foley, H. James Ford, Russel Hirsch, James Grinnan, D. Dunbar Ivy, Steven M. Kawut, Jamie L.W. Kennedy, James R. Klinger, Peter J. Leary, Sula Mazimba, Gautam Ramani, Amresh Raina, James Runo, John W. Swisher, Nidhy P. Varghese, R.J. White, Timothy Williamson, Delphine Yung, Roham T. Zamanian, Dianne Zwicke - Journal of the American Heart Association 2022 cited by 234

  9. Definitions and Diagnosis of Pulmonary Hypertension

    Authors: Marius M. Hoeper, Harm Jan Bogaard, Robin Condliffe, Robert P. Frantz, Dinesh Khanna, Marcin Kurzyna, David Langleben, Alessandra Manes, Toru Satoh, Fernando Torres, Martin R. Wilkins, David B. Badesch - Journal of the American College of Cardiology 2013 cited by 1,759

  10. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry

    Authors: Raymond L. Benza, Dave P. Miller, Robyn J. Barst, David B. Badesch, Adaani Frost, Michael D. McGoon - CHEST Journal 2012 cited by 1,107

  11. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

    Authors: Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Fernando Torres, Adaani Frost, Hossein Ardeschir Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin - Circulation 2008 cited by 1,080

  12. Definition, classification and diagnosis of pulmonary hypertension

    Authors: Gábor Kovács, Sonja Bartolome, Christopher P. Denton, Michael Α. Gatzoulis, Sue Gu, Dinesh Khanna, David B. Badesch, David Montani - European Respiratory Journal 2024 cited by 371

  13. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

    Authors: Christopher J. Rhodes, Ken Batai, Marta Bleda, Matthias Haimel, Laura Southgate, Marine Germain, Michael W. Pauciulo, Charaka Hadinnapola, Jurjan Aman, Barbara Girerd, Amit Arora, Jo Knight, Ken B. Hanscombe, Jason H. Karnes, Marika Kaakinen, Henning Gall, Anna Ulrich, Lars Harbaum, Inês Cebola, Jorge Ferrer, Katie A. Lutz, Emilia M. Swietlik, Ferhaan Ahmad, Philippe Amouyel, Stephen L. Archer, Rahul Argula, Eric D. Austin, David B. Badesch, Sahil Bakshi, Christopher F. Barnett, Raymond L. Benza, Nitin Bhatt, Harm Jan Bogaard, Charles D. Burger, Murali M. Chakinala, Colin Church, Gerry Coghlan, Robin Condliffe, Paul A. Corris, Cesare Danesino, Stéphanie Debette, C. Gregory Elliott, Jean Elwing, Mélanie Eyries, Terry Fortin, André Franke, Robert P. Frantz, Adaani Frost, Joe G. N. Garcia, Stefano Ghio, Hossein-Ardeschir Ghofrani, J. Simon R. Gibbs, John B. Harley, Hua He, Nicholas S. Hill, Russel Hirsch, Arjan C. Houweling, Luke Howard, D. Dunbar Ivy, David G. Kiely, James R. Klinger, Gábor Kovács, Tim Lahm, Matthias Laudes, Rajiv D. Machado, Robert V. MacKenzie Ross, Keith Marsolo, Lisa J. Martin, Shahin Moledina, David Montani, Steven D. Nathan, Michael Newnham, Andrea Olschewski, Horst Olschewski, Ronald J. Oudiz, Willem H. Ouwehand, Andrew J. Peacock, Joanna Pepke‐Żaba, Zia Ur Rehman, Ivan M. Robbins, Dan M. Roden, Erika B. Rosenzweig, Ghulam Saydain, Laura Scelsi, Robert Schilz, Werner Seeger, Christian M. Shaffer, Robert W. Simms, Marc A. Simon, Olivier Sitbon, Jay Suntharalingam, Haiyang Tang, Alexander Tchourbanov, Thenappan Thenappan, Fernando Torres, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, Quinten Waisfisz, Anna K. Walsworth and 18 more - The Lancet Respiratory Medicine 2018 cited by 213

  14. Bosentan Therapy for Pulmonary Arterial Hypertension

    Authors: Lewis J. Rubin, David B. Badesch, Robyn J. Barst, Nazzareno Galiè, Carol M. Black, Anne Keogh, Tomás Pulido, Adaani Frost, Sébastiên Roux, Isabelle Leconte, Michael J. Landzberg, Gérald Simonneau - New England Journal of Medicine 2002 cited by 2,720

  15. Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

    Authors: Harrison W. Farber, Dave P. Miller, Abby Poms, David B. Badesch, Adaani Frost, Erwan Muros‐Le Rouzic, Alain Romero, Wade W. Benton, C. Gregory Elliott, Michael D. McGoon, Raymond L. Benza - CHEST Journal 2015 cited by 520

  16. Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial

    Authors: Roham T. Zamanian, David B. Badesch, Lorinda Chung, Robyn T. Domsic, Thomas A. Medsger, Ashley Pinckney, Lynette Keyes-Elstein, Carla D’Aveta, Meagan Spychala, R. James White, Paul M. Hassoun, Fernando Torres, Andrew J. Sweatt, Jerry A. Molitor, Dinesh Khanna, Holden T. Maecker, Beverly Welch, Ellen Goldmuntz, Mark R. Nicolls - American Journal of Respiratory and Critical Care Medicine 2021 cited by 183

  17. A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

    Authors: Robyn J. Barst, Lewis J. Rubin, Walker Long, Michael D. McGoon, Stuart Rich, David B. Badesch, Bertron Μ. Groves, Victor F. Tapson, Robert C. Bourge, Bruce H. Brundage, Spencer K. Koerner, David Langleben, Cesar A. Keller, Srinivas Murali, Barry F. Uretsky, Linda Clayton, Maria M. Jöbsis, Shelmer D. Blackburn, Denise Shortino, James W. Crow - New England Journal of Medicine 1996 cited by 2,695

  18. Diagnosis of pulmonary hypertension

    Authors: Adaani Frost, David B. Badesch, J. Simon R. Gibbs, Deepa Gopalan, Dinesh Khanna, Alessandra Manes, Ronald J. Oudiz, Toru Satoh, Fernando Torres, Adam Torbicki - European Respiratory Journal 2018 cited by 492

  19. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

    Authors: Rubin M. Tuder, Bertron Μ. Groves, David B. Badesch, N. F. Voelkel - 1994 cited by 803

  20. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Authors: Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch, Robyn J. Barst, Harrison W. Farber, Jonathan R. Lindner, Michael A. Mathier, Michael D. McGoon, Myung H. Park, Robert S. Rosenson, Lewis J. Rubin, Victor F. Tapson, John Varga - Circulation 2009 cited by 2,355

  21. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension

    Authors: Raymond L. Benza, Mardi Gomberg‐Maitland, Dave P. Miller, Adaani Frost, Robert P. Frantz, Aimee J. Foreman, David B. Badesch, Michael D. McGoon - CHEST Journal 2011 cited by 557

  22. Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL

    Authors: Lorinda Chung, Juliana Liu, Lori Parsons, Paul M. Hassoun, Michael D. McGoon, David B. Badesch, Dave P. Miller, Mark R. Nicolls, Roham T. Zamanian - CHEST Journal 2010 cited by 432

  23. The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States

    Authors: Adaani Frost, David B. Badesch, Robyn J. Barst, Raymond L. Benza, C. Gregory Elliott, Harrison W. Farber, Abby Krichman, Theodore G. Liou, Gary E. Raskob, Prieya Wason, Kathleen Feldkircher, Michelle Turner, Michael D. McGoon - CHEST Journal 2010 cited by 351

  24. Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

    Authors: Victor F. Tapson, Fernando Torres, F. Kermeen, Anne Keogh, Roblee P. Allen, Robert P. Frantz, David B. Badesch, Adaani Frost, Shelley Shapiro, Kevin Laliberte, J Sigman, Carl Arneson, Nazzareno Galiè - CHEST Journal 2012 cited by 376